VolitionRx Limited (NYSE:NYSE:VNRX) Q2 2022 Earnings Conference Call August 11, 2022 08:30 AM ET Company Participants Scott Powell - IR Cameron Reynolds - CEO Dr.
/PRNewswire/ VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a business update for the second quarter ended June.
Almirall launches new call to find innovative therapies for skin diseases pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
Avicanna Inc revealed that the National Basketball Players Association (NBPA) has announced a new multi-year partnership with Re+Play, the performance-based.
Volitionrx (VNRX) Presents New NETs Data streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.